![Shao Lee Lin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Shao Lee Lin
Amministratore Delegato presso
CUE BIOPHARMA, INC.
Patrimonio netto: 21 M $ in data 30/06/2026
Profilo
Shao Lee Lin was the founder of ACELYRIN, Inc., founded in 2020, serving as Chief Executive Officer & Director from 2020 to 2024.
Current jobs include President, CEO, CFO & Director at Cue Biopharma, Inc. since 2026, and Director at Surrozen Operating, Inc. since 2021.
Former jobs include Director at Principia Biopharma, Inc. from 2019 to 2020; Independent Director at Surrozen, Inc. from 2021 to 2026; Independent Director at Third Harmonic Bio, Inc. from 2020 to 2023; VP-Inflammation & Respiratory Development at Gilead Sciences, Inc. from 2012 to 2015; VP-Therapeutic Areas & Development Excellence at AbbVie, Inc. from 2015 to 2017; Chief Scientific Officer, EVP, Head-R&D at Horizon Therapeutics Ltd. (Ireland) from 2018 to 2020; and Trustee at Lake Forest College from 2018 to 2020.
Education includes undergraduate studies at William Marsh Rice University and a doctorate from The Johns Hopkins University School of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
CUE BIOPHARMA, INC. 15,6% | 09/07/2026 | 655.074 ( 15,6% ) | 21 M $ | 30/06/2026 |
SURROZEN INC 0,02% | 14/05/2025 | 2.341 ( 0,02% ) | 60 749 $ | 30/06/2026 |
Posizioni attive di Shao Lee Lin
| Società | Posizione | Inizio |
|---|---|---|
| CUE BIOPHARMA, INC. | Amministratore Delegato | 30/04/2026 |
Surrozen Operating, Inc.
 Surrozen Operating, Inc. BiotechnologyHealth Technology Discovers and develops novel regenerative medicines | Direttore/Membro del Consiglio | 02/02/2021 |
Precedenti posizioni note di Shao Lee Lin
| Società | Posizione | Fine |
|---|---|---|
| SURROZEN, INC. | Direttore/Membro del Consiglio | 26/01/2026 |
| ACELYRIN, INC. | Fondatore | 08/05/2024 |
| THIRD HARMONIC BIO, INC. | Direttore/Membro del Consiglio | 17/01/2023 |
| PRINCIPIA BIOPHARMA INC. | Direttore/Membro del Consiglio | 28/09/2020 |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Direttore Tecnico/Scientifico/R&S | 23/01/2020 |
Formazione di Shao Lee Lin
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
58
Relazioni di 1° grado
12
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 12 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Principia Biopharma, Inc.
 Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a R&D driven and AI-powered biopharma company | Health Technology |
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Horizon Therapeutics Ltd. (Ireland)
 Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Discovers, develops and manufactures pharmaceuticals for autoimmune & inflammatory diseases | Health Technology |
Rice University
 Rice University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lake Forest College
 Lake Forest College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cue Biopharma, Inc.
 Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Surrozen Operating, Inc.
Surrozen Operating, Inc. BiotechnologyHealth Technology Discovers and develops novel regenerative medicines | Health Technology |
Third Harmonic Bio, Inc.
 Third Harmonic Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of allergic and immune diseases and disorders | Health Technology |
ACELYRIN, Inc.
 ACELYRIN, Inc. Pharmaceuticals: MajorHealth Technology Operates as late-stage clinical biopharmaceutical company which focuses on identifying, acquiring and accelerating the development & commercialization of medicines | Health Technology |
Surrozen, Inc.
 Surrozen, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that discovering and developing drug candidates | Health Technology |
